Tus kws kho mob
Cannabidiol - Medicaid
Kev Tso Cai Ua Ntej
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2181 - 2190 ntawm 3685
Tus kws kho mob
Cannabidiol - Commercial
Kev Tso Cai Ua Ntej
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P35-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P33-21 Change to Medical Review Process for Outpatient Therapies Services
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2021
Tus kws kho mob
Zokinvy (lonafarnib) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Samsca® (tolvaptan) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
QP50-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective August 1, 2021
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 09, 2021
Tus kws kho mob
QP51-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 25, 2021
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 09, 2021
Tus kws kho mob
QP47-21 Audio-Only Telehealth Visits do not Meet Requirements for Risk Adjustment Face-to-Face Requirement
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 09, 2021
Tus kws kho mob
upcoming-policies-effective-august-2-2021.pdf